Home > Industry Projects > Oncology > Erbitux (Cetuximab) - Investigational Biological
Erbitux has been approved for use in metastatic colorectal cancer in both Switzerland and the US.
Copyright 2007SPG Media Limited a subsidiary of SPG Media Group PLC
